Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model

Journal of Ethnopharmacology

Volumn 150, Issue 2, 2013, Pages 560-567

  Li, Yan Hong ^a   Kan, Winnie Lai Ting ^a   Li, Na ^a   Lin, Ge ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

Cytotoxicity; HepG2 cell; In vitro model; Pyrrolizidine alkaloids

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; CLIVORINE; PLATYPHYLLINE; PYRROLIZIDINE ALKALOID; RETRORSINE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; GYNURA SEGETUM; HERB; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER TOXICITY; MODEL; NONHUMAN;

GYNURA SEGETUM;

CYTOTOXICITY; HEPG2 CELL; IN VITRO MODEL; PYRROLIZIDINE ALKALOIDS;

ASTERACEAE; CELL PROLIFERATION; CELL SURVIVAL; HEP G2 CELLS; HUMANS; PLANT EXTRACTS; PYRROLIZIDINE ALKALOIDS; TOXICITY TESTS;

EID: 84887424094     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.09.010     Document Type: Article

References (47)

1. N. Abraham, R. Carty, D. DuFour, and M. Pincus Clinical enzymology R. McPherson, M. Pincus, Henry's Clinical Diagnosis and Management by Laboratory Methods 2006 Saunders Elsevier Philadelphia 273 295
2. M. Balls, B. Blaauboer, D. Brusick, D. Frazier, D. Lamb, M. Pemberton, C. Reinhardt, M. Roberfroid, H. Rosenkranz, B. Schmid, H. Spielmann, A.L. Stammati, and E. Walum Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures Alternatives to Laboratory Animals 18 1990 313 337
3. R.J. Bensaude, C. Monegier du Sorbier, A.P. Jonville-Bera, E. Autret, F. Ouyahya, and E.H. Metman Veno-occlusive disease after prolonged treatment with senecionine (Hemoluol) Gastroenterologie Clinique et Biologique 22 1998 363 364
4. E. Borenfreund, and J.A. Puerner Toxicity determined in vitro by morphological alterations and neutral red absorption Toxicology Letters 24 1985 119 124
5. K.K. Chen, N.H. Paul, and L.R. Charles The action and toxicity of platyphylline and seneciphylline Journal of Pharmacology and Experimental Therapeutics 68 1940 130 140
6. M.Y. Chen, J.T. Cai, Q. Du, L.J. Wang, J.M. Chen, and L.M. Shao Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline Hepatobiliary and Pancreatic Diseases International 7 2008 395 400
7. B.L. Copple, C.M. Rondelli, J.F. Maddox, N.C. Hoglen, P.E. Ganey, and R.A. Roth Modes of cell death in rat liver after monocrotaline exposure Toxicological Sciences 77 2004 172 182
8. N. Dai, Y.C. Yu, T.H. Ren, J.G. Wu, Y. Jiang, L.G. Shen, and J. Zhang Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature World Journal of Gastroenterology 13 2007 1628 1631
9. D.M. Dambach, B.A. Andrews, and F. Moulin New technologies and screening strategies for hepatotoxicity: use of in vitro models Toxicologic Pathology 33 2005 17 26
10. L.D. DeLeve, X. Wang, J.F. Kuhlenkamp, and N. Kaplowitz Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease Hepatology 23 1996 589 599
11. L.D. DeLeve, R.S. McCuskey, X. Wang, L. Hu, M.K. McCuskey, R.B. Epstein, and G.C. Kanel Characterization of a reproducible rat model of hepatic veno-occlusive disease Hepatology 29 1999 1779 1791
12. J.A. Edgar, E. Roeder, and R.J. Molyneux Honey from plants containing pyrrolizidine alkaloids: a potential threat to health Journal of Agricultural and Food Chemistry 50 2002 2719 2730
13. P.P. Fu, Q. Xia, G. Lin, and M.W. Chou Pyrrolizidine alkaloids- genotoxicity, metabolism enzymes, metabolic activation, and mechanisms Drug Metabolism Reviews 36 2004 1 55
14. H. Gao, N. Li, J.Y. Wang, S.C. Zhang, and G. Lin Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids Journal of Digestive Diseases 13 2012 33 39
15. E.E. Golli-Bennour, A. Bouslimi, O. Zouaoui, S. Nouira, A. Achour, and H. Bacha Cytotoxicity effects of amiodarone on cultured cells Experimental and Toxicologic Pathology 64 2010 425 430
16. D. Guo, T. Fu, J.A. Nelson, R.A. Superina, and H.E. Soriano Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride Transplantation 73 2002 1818 1824
17. L.L. Ji, M. Zhang, Y.C. Sheng, and Z.T. Wang Pyrrolizidine alkaloid clivorine induces apoptosis in human normal liver L-02 cells and reduces the expression of p53 protein Toxicology in Vitro 19 2005 41 46
18. A.S. Ka, G. Michel, P. Imbert, I. Diakhaté, and M.N. Seye Hepatic veno-occlusive disease due to dietary toxins in a five-year-old child in Senegal Medecine Tropicale 66 2006 514 515
19. H.Y. Kim, F.R. Stermitz, R.J. Molyneux, D.W. Wilson, D. Taylor, and R.A. Coulombe Jr. Structural influences on pyrrolizidine alkaloid-induced cytopathology Toxicology and Applied Pharmacology 122 1993 61 69
20. P. Knox, P.F. Uphill, J.R. Fry, D. Benford, and M. Balls The FRAME multicentre project on in vitro cytotoxicity Food Chemical Toxicology 24 1986 457 463
21. F.C. Kull Jr, and P. Cuatrecasas Estimation of cell number by neutral red content. Applications for proliferative and survival assays Applied Biochemistry and Biotechnology 8 1983 97 103
22. N. Li, Q.S. Xia, J.Q. Ruan, P.P. Fu, and G. Lin Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs Current Drug Metabolism 12 2011 823 834
23. G. Lin, P. Rose, K.B. Chatson, E.M. Hawes, X.G. Zhao, and Z.T. Wang Characterization of two structural forms of otonecine-type pyrrolizidine alkaloids from Ligularia hodgsonii by NMR spectroscopy Journal of Natural Products 63 2000 857 860
24. G. Lin, Y.Y. Cui, and E.M. Hawes Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid Drug Metabolism and Disposition 28 2000 1475 1483
25. G. Lin, Y.Y. Cui, X.Q. Liu, and Z.T. Wang Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine Chemical Research in Toxicology 15 2002 1421 1428
26. G. Lin, Y.Y. Cui, and X.Q. Liu Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat Chemical Research in Toxicology 16 2003 768 774
27. G. Lin, J. Tang, X.Q. Liu, Y. Jiang, and J. Zheng Deacetylclivorine: a gender-selective metabolite of clivorine formed in female SD rat liver microsomes Drug Metabolism and Disposition 35 2007 607 613
28. G. Lin, J.Y. Wang, N. Li, M. Li, H. Gao, Y. Ji, F. Zhang, H. Wang, Y. Zhou, Y. Ye, H.X. Xu, and J. Zheng Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum Journal of Hepatology 54 2011 666 673
29. A.R. Mattocks Chemistry and Toxicology of Pyrrolizidine Alkaloids 1986 Academic Press London
30. A.R. Mattocks, and I. Bird Alkylation by dehydroretronecine, a cytotoxic metabolite of some pyrrolizidine alkaloids: an in vitro test Toxicology Letters 16 1983 1 8
31. M.G. Neuman, A.Y. Jia, and V. Steenkamp Senecio latifolius induces in vitro hepatocytotoxicity in a human cell line Canadian Journal of Physiology and Pharmacology 85 2007 1063 1075
32. P.J. O'Brien, W. Irwin, D. Diaz, E. Howard-Cofield, C.M. Krejsa, M.R. Slaughter, B. Gao, N. Kaludercic, A. Angeline, P. Bernardi, P. Brain, and C. Hougham High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Archives of Toxicology 80 2006 580 604
33. S. Perrot, H. Dutertre-Catella, C. Martin, J.M. Warnet, and P. Rat A new nondestructive cytometric assay based on resazurin metabolism and an organ culture model for the assessment of corneal viability Cytometry A 55 2003 7 14
34. R. Rasenack, and H. Wiedenfeld Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin Fetal Diagnosis and Therapy 18 2003 223 225
35. E. Roeder Medicinal plants in Europe containing pyrrolizidine alkaloids Pharmazie 50 1995 83 98
36. E. Roeder Medicinal plants in China containing pyrrolizidine alkaloids Pharmazie 55 2000 711 726
37. J.Q. Ruan, N. Li, Q.S. Xia, P.P. Fu, S.Y. Peng, Y. Ye, and G. Lin Characteristic ion clusters as determinants for the identification of pyrrolizidine alkaloid N-oxides in pyrrolizidine alkaloid-containing natural products using HPLC-MS analysis Journal of Mass Spectrometry 47 2012 331 337
38. W.G. Schoonen, W.M. Westerink, J.A. de Roos, and E. Débiton Cytotoxic effects of 100 reference compounds on HepG2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I. Mechanistic assays on ROS, glutathione depletion and calcein uptake Toxicology in Vitro 19 2005 505 516
39. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening Journal of the National Cancer Institute 82 1990 1107 1112
40. B.L. Stegelmeier, J.A. Edgar, S.M. Colegate, D.R. Gardner, T.K. Schoch, R.A. Coulombe, and R.J. Molyneux Pyrrolizidine alkaloid plants, metabolism and toxicity Journal of Natural Toxins 8 1999 95 116
41. H. Tuschl, and C.E. Schwab Flow cytometric methods used as screening tests for basal toxicity of chemicals Toxicology in Vitro 18 2004 483 491
42. A. Van Summeren, J. Renes, F.G. Bouwman, J.P. Noben, J.H. Van Delft, J.C. Kleinjans, and E.C. Mariman Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells Toxicological Sciences 120 2011 109 122
43. X. Wang, G.C. Kanel, and L.D. DeLeve Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat Hepatology 31 2000 428 434
44. H. Wiedenfeld, E. Roeder, T. Bourauel, and J. Edgar Pyrrolizidine Alkaloids. Structure and Toxicity 2008 University Press Bonn
45. Q. Xia, J. Yan, M.W. Chou, and P.P. Fu Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine Toxicology Letters 178 2008 77 82
46. C.C. Yan, R.A. Cooper, and R.J. Huxtable The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver Toxicology and Applied Pharmacology 133 1995 277 284
47. Y.C. Yang, J. Yan, D.R. Doerge, P.C. Chan, P.P. Fu, and M.W. Chou Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo Chemical Research in Toxicology 14 2001 101 109